| Similar Articles |
|---|
 |
American Family Physician
September 1, 2006
Heidelbaugh & Sherbondy |
Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment Part II of a two-part article on treatments that can help alleviate complications due to cirrhosis and chronic liver failure.   |
American Family Physician
November 15, 2001
Thomas R. Riley |
Preventive Strategies in Chronic Liver Disease: Part II. Cirrhosis Cirrhosis is a diffuse process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules. Strategies have been established to prevent complications in patients with cirrhosis... |
Nurse Practitioner
July 2008
Lynn A. Kelso |
Cirrhosis: Caring for Patients with End-stage Liver Failure Caring for patients with end-stage liver disease can be very challenging for NPs. |
The Motley Fool
November 18, 2009
Brian Orelli |
Drug Lowers Cholesterol; Stock Follows ISIS has a hard time at American Heart Association despite good efficacy data. |
American Family Physician
September 1, 2006
Heidelbaugh & Bruderly |
Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evaluation Part I of a two-part on how to diagnose and determine treatment for cirrhosis and chronic liver failure. |
American Journal of Nursing
February 2010
Melissa M. Smith |
Emergency: Variceal Hemorrhage from Esophageal Varices Associated with Alcoholic Liver Disease This article describes alcoholic cirrhosis and its complications, discusses the etiology of esophageal varices and the risk factors for hemorrhage, and addresses emergent treatment. |
Nurse Practitioner
December 2009
Gujral & Collantes |
Understanding Viral Hepatitis: A guide for primary care Recent advancements in the field of genomics and proteomics technology have given researchers and clinicians more insight on disease pathogenesis and helped create more tailored approaches to the treatment of these conditions. |
American Family Physician
September 1, 2006 |
Cirrhosis and Chronic Liver Failure: What You Should Know The basics about cirrhosis and chronic liver failure. |
American Family Physician
January 15, 2004
Roche & Kobos |
Jaundice in the Adult Patient Jaundice in an adult patient can be caused by a wide variety of benign or life-threatening disorders. Organizing the differential diagnosis by prehepatic, intrahepatic, and posthepatic causes may help make the work-up more manageable. |
American Family Physician
March 15, 2005
Paul T. Giboney |
Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient Mild elevations in liver chemistry tests can reveal serious underlying conditions or have transient and benign etiologies. If elevations persist after an appropriate period of observation, further testing may include ultrasonography and other serum studies. |
HHMI Bulletin
Fall 2012
Sarah C. P. Williams |
The Fat You Can't See Without the liver acting as a filter and energy producer, a person can't survive, and no artificial organ can perform all of its duties. But in one in three Americans -- and similar numbers in other developed nations -- the liver has lost its luster. |
American Family Physician
August 15, 2005
Mark H. Ebell |
Point-of-Care Guides What is the prognosis for a patient with terminal cancer? |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
The Motley Fool
August 5, 2010
Brian Orelli |
Blockbuster Efficacy! Not-So-Blockbuster Safety! Isis and Genzyme's wonder drug has not-so-wonderful side effects. Still. |
Nursing
October 2011
Habib & Saunders |
The yellow bird of jaundice: Recognizing biliary obstruction This article describes the various possible causes of biliary obstruction, diagnostic studies and treatment options, and nursing considerations for patients with this disorder. |
American Family Physician
June 1, 2006
Bayard, Holt & Boroughs |
Nonalcoholic Fatty Liver Disease Nonalcoholic fatty liver disease is a common condition associated with metabolic syndrome. It is the most common cause of elevated liver enzymes in U.S. adults, and is diagnosed after ruling out other causes of steatosis, particularly infectious hepatitis and alcohol abuse. |
Nursing
March 2009
Mary G. McKinley |
Recognizing and Responding to Acute Liver Failure By quickly recognizing the signs and symptoms of acute liver failure, you can help your patient improve his odds of surviving this often-deadly condition. |
Nursing
February 2012
Duncan et al. |
Early warning systems: The next level of rapid response Cardiac arrests in hospitals are usually preceded by observable signs of deterioration, which often appear 6 to 8 hours before the arrest occurs. |
Nursing
December 2008
Susan Simmons Holcomb |
Caring for a patient with chronic hepatitis C Teach your patient about improved treatments that can help him deal with this potentially deadly infection. |
Entrepreneur
June 2009
George Solomon |
Quiz: Risk Assessment Calculator See if you score high on the financial fitness quiz. |
American Family Physician
November 1, 2001
Thomas R. Riley |
Preventive Strategies in Chronic Liver Disease Chronic liver disease is the 10th leading cause of death in the United States. Preventive care can significantly reduce the progression of liver disease. Part I: Alcohol, Vaccines, Toxic Medications and Supplements, Diet and Exercise... |
The Motley Fool
February 11, 2010
Brian Orelli |
A Wonder Drug With Not-So-Wonderful Side Effects Wonder drug or not, Isis Pharmaceuticals and Genzyme's cholesterol drug mipomersen's sales will be limited by side effects. |
Nurse Practitioner
March 2009
Patricia Weyland |
Warfarin Therapy Management :Tap in to New Ways to Slow the Clot Patients on warfarin require close monitoring in order to decrease their risk of clotting, while also decreasing their risk of bleeding. |
American Family Physician
October 1, 2005
Francine Rainone |
Milk Thistle Milk thistle has been used as a cytoprotectant for the treatment of liver disease, for the treatment and prevention of cancer, and as a supportive treatment of Amanita phalloides poisoning. Clinical studies are largely heterogeneous and contradictory. |
Chemistry World
September 11, 2013
Emma Stoye |
Call to overhaul liver toxicity testing Outdated assays for monitoring liver health could have caused dozens of drug candidates to be wrongly scrapped during development, according to new research. |
The Motley Fool
April 29, 2005
Dayana Yochim |
Why's My FICO Score Wacky? Wonder why your credit scores are so wildly different? It's because the scoring systems are wildly different. |
The Motley Fool
December 16, 2011
Brian Orelli |
Safety (Still) Trumps Acquisitions in Hep C Pharmasset announced it was discontinuing all treatment arms in one of its phase 2b trials that contain the drug PSI-938. The drug candidate caused laboratory abnormalities in tests associated with liver function. |
CIO
October 29, 2015
Martha Heller |
Amgen uses algorithms to venture into digital healthcare A senior vice president of global marketing and commercial development, says she's working with the CIO to set up a digital healthcare organization that can help physicians better predict how patients will respond to therapies. |
Science News
January 21, 2006
Janet Raloff |
Caffeinated Liver Defense A 20-year long study recently concluded people who routinely drank more than two cups of coffee or tea per day faced only half the risk of being hospitalized with cirrhosis and other types of serious liver disease as did people consuming less of these drinks. |
American Family Physician
March 15, 2004 |
Management of Hepatitis C: Evaluating Suitability for Drug Therapy Chronic hepatitis C virus infection is a common and serious disease. Although an estimated 2.7 million persons in the United States have this disease, most have not yet been diagnosed. |
The Motley Fool
September 8, 2010
Brian Orelli |
You Must Realize This Drug Works by Now Vertex concludes its phase 3 trials with another win. |
HHMI Bulletin
May 2010
Sarah C.P. Williams |
Lab-Grown Liver New cell culture system solves problem of growing liver cells. |
The Motley Fool
September 7, 2010
Luke Timmerman |
Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too. |
The Motley Fool
June 20, 2006
Dayana Yochim |
Fake Credit Scores for Sale You might be surprised how label-conscious your lender really is. No matter what the scoring scale, all of these systems are designed to achieve one goal -- to see how risky it is to do business with you based on your past behavior. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
The Motley Fool
June 26, 2009
Tim Beyers |
Someone at Apple Should Pay Earlier reports from The Wall Street Journal were confirmed this week: Apple chief executive Steve Jobs had a liver transplant two months ago at a Tennessee hospital. This should have been disclosed sooner. |
Pharmaceutical Executive
January 1, 2013
Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
AskMen.com
Terence Channon |
4 Steps: Raise Your Credit Score When you raise your credit score, you raise the number of advantages available to you in the real world. |
The Motley Fool
December 29, 2004
Dayana Yochim |
What's Your Credit Karma? Know your credit score -- it's important and it affects your life. |
HBS Working Knowledge
November 28, 2011
Dennis Fisher |
Rethinking the Fairness of Organ Transplants Business researchers at Harvard and MIT are rethinking how kidney transplants are allocated to give patients longer lives. |
The Motley Fool
June 23, 2006
Selena Maranjian |
Your Credit Score May Be Costing You Big Bucks Check out the actual range of your losses due to credit discrepancies -- it might frighten you. |
Salon.com
December 8, 2000
Jenna Glatzer |
A genetic death sentence Doctors routinely deny heart transplants to the mentally retarded... |
The Motley Fool
February 14, 2007
Mary Dalrymple |
Know Your Score Find out what lenders really think of you. Your credit score is the result of a statistical computation meant to tell lenders whether it's likely that you'll default on a loan. |
The Motley Fool
December 6, 2005
Dayana Yochim |
FICO Babble The money shrink is in to help you make sense of your credit score. Together we're going to tackle your deepest FICO fears head-on. |
Pharmaceutical Executive
June 1, 2014
Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
Inc.
October 2008 |
Cleaning Up Your Credit Here are four tips for lowering your interest rate and improving your credit score. |
Pharmaceutical Executive
September 1, 2012
Al Topin |
Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty. |
IEEE Spectrum
February 2005
Carol Ezzell Webb |
The Body Shops Part human, part machine, replacement organs may one day extend your life |
Pharmaceutical Executive
April 1, 2012
Feam & Lagus |
Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help. |
The Motley Fool
March 31, 2011
Brian Orelli |
Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones? |
